Health costs and income in euros before and after a diagnosis of idiopathic pulmonary fibrosis (IPF) diagnosis
Before | After | |||||
IPF | Control | p-value | IPF | Control | p-value | |
Inpatient treatment | 1040±3785 | 904±3740 | 0.970 | 14 683±18 440 | 1528±5500 | <0.0001 |
Outpatient treatment | 266±567 | 223±1198 | 0.302 | 1198±3314 | 426±1673 | <0.0001 |
Medication | 481±630 | 391±700 | 0.001 | 1151±1300 | 534±830 | <0.0001 |
National Health Insurance | 243±231 | 246±339 | 1.0 | 464±476 | 325±372 | <0.0001 |
Direct costs# | 2030 | 1764 | 17 495 | 2813 | ||
Employment income | 13 603±23 852 | 15 558±24 684 | 0.280 | 5164±15 506 | 10 841±20 854 | <0.0001 |
Indirect costs¶ | 1955 | 5677 | ||||
Public transfer payments+ | 10 726 | 10 194 | 12 478 | 11 653 | ||
Total costs§ | 3985 | 1764 | 23 173 | 2813 | ||
Net costsƒ | 2753 | 21 184 |
Data are presented as mean±sd or mean value per individual, unless otherwise stated. #: the sum of inpatient treatment, outpatient treatment, medication and national health insurance; ¶: the difference in employment income between cases and controls; +: the sum of pensions, other public transfer payments and publicly funded sickness benefits; §: sum of direct and indirect costs; ƒ: the difference between direct costs, indirect costs and public transfer payments.